AVITA Medical, Inc. Research And Development Expense
AVITA Medical, Inc. (RCEL) reported Research And Development Expense of AUD 14.36 million for the 12-month period ending 2019-06-30, per its 20-F/A filed 2019-11-19.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2019-11-19
| Period end | Research And Development Expense 12 month |
|---|---|
| 2019-06-30 | 14.36M AUD 20-F/A · filed 2019-11-19 |
| 2018-06-30 | 12.61M AUD 20-F/A · filed 2019-11-19 |
| 2017-06-30 | 11.16M AUD 20-F/A · filed 2019-11-19 |